Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

91.20
+2.773.14%
Volume:335.55K
Turnover:30.32M
Market Cap:7.20B
PE:-25.35
High:91.69
Open:88.59
Low:87.37
Close:88.43
52wk High:103.00
52wk Low:19.45
Shares:78.95M
Float Shares:54.63M
Volume Ratio:0.83
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5975
EPS(LYR):-2.9830
ROE:-32.09%
ROA:-19.21%
PB:7.61
PE(LYR):-30.57

Loading ...

Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Dec 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities